WOMEN'S HEALTH

Evidence-based decision support for women’s care, from the reproductive years through postmenopause

Clinical decision support that looks at the whole picture, connecting body systems, by interpreting each patient's labs, symptoms and wearable data in the context of her life stage

Support personalized, continuous care for women at every life stage

Four capabilities that support individualized treatment through the menopause transition and beyond.

Sex-specific evidence

Analyses and recommendations draw on research in women first, and flag where evidence in women is limited

Continuous symptom capture

Patients log vasomotor symptoms, sleep, mood, cognition and bleeding daily, alongside validated instruments

A faster feedback loop

See how symptoms trend after each change in formulation, dose or route, between visits rather than waiting until the next one.

Individualized treatment

Hormone and non-hormone therapies, lifestyle and supplements, each with its evidence grade, each with supporting research and expected effects.

Recommendations grounded in research in women

Women remain underrepresented in many of the trials that inform prescribing, and most drug doses are not sex-specific. Longevitix draws on a curated women’s health knowledge base, prioritizes data from female populations, and links every recommendation to its sources.

A treatment plan card listing hormone therapy options, each tagged for women’s health with its expected effect, and a citation popover for the 2020 NAMS genitourinary syndrome of menopause position statement.

01

Female-specific evidence at the point of prescribing

Most clinical decision support draws on sex-pooled trial data. Here, findings specific to women appear where the prescribing choice is made, such as the lower VTE risk of transdermal versus oral estrogen and the undertreatment of women with statins.

02

A whole-body plan, beyond hormones

Bone, muscle, sleep, lipids and vasomotor symptoms sit in one plan, treating menopause as a multi-system transition.

03

Evidence graded on every option

Each option carries a High, Moderate or Low grade, so a guideline-backed therapy and an emerging supplement never carry equal weight.

Track each patient’s response between visits

Assess the whole patient through a women's health lens

Longevitix reviews the patient's entire health, including domains specific to women, such as hormones and cycles, bone health and pelvic health. Results are read in the context of her life stage and connected across systems: declining estrogen, for example, is read alongside sleep, mood, bone density and ApoB.

READ IN THE CONTEXT OF LIFE

  • Reproductive years
  • Perimenopause
  • Menopause
  • Postmenopause
  • Hormones and menstrual cycles
  • Gynecologic and reproductive health
  • Cancer screening
  • Sexual health
  • Pelvic and urinary health
  • Hair and skin
  • Bone and muscle

Questions Providers Ask Us About Women's Health

  • What evidence are the recommendations based on?

    A curated knowledge base that prioritizes research in female populations, alongside current guidance from society guidelines. Each recommendation cites its sources and evidence grade.

  • What does the daily journal capture?

    Patient-reported symptoms, sleep, mood and cycle, shown alongside labs and wearable data.

  • How does it support hormone therapy management?

    It presents hormone and non-hormone therapy options with supporting research and expected effects, then tracks symptoms and response after each adjustment. The physician makes every decision.

  • Is women's health a separate module?

    No. Life stage is captured at intake and informs all clinical domains.

Bring sex-specific evidence and continuous monitoring to your women's health practice

Book Demo
ask ai about us
ChatGPT
ChatGPT
Claude
Claude